Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alastair J. Clemow currently holds 35,000 shares of Aevi Genomic Medicine, Inc. (GNMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alastair J. Clemow has been a net buyer of GNMX stock. They have purchased $25.0K and sold $0 worth of shares.
Alastair J. Clemow's most recent insider trade was on Jan 1, 2021, when they purchased 12,500 shares at $0.00 per share.
Alastair J. Clemow serves as Executive at Aevi Genomic Medicine, Inc. (GNMX). They have executed 3 insider transactions totaling $25.0K over their tenure at the company.
Alastair J. Clemow holds the position of Executive at Aevi Genomic Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Alastair J. Clemow has shown a buying trading pattern, with $25.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Alastair J. Clemow was on Oct 17, 2017, when they purchased $25.0K worth of GNMX shares. This transaction involved 19,841 shares at $1.26 per share.
Alastair J. Clemow currently owns 35,000 shares of Aevi Genomic Medicine, Inc. (GNMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alastair J. Clemow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alastair J. Clemow has 3 Form 4 filings on record as an insider at Aevi Genomic Medicine, Inc..
Set alerts for Alastair J. Clemow and 40,000+ other insiders.